98.48%，保证结果准确可靠。产品检测自然感染或特定疫苗产生的抗棘突/RBD 蛋白的中和抗体活性，15 分钟获取报告，适用于个体免疫状态评估。复星诊断将持续关注

冠状病毒刺突蛋白S(S1)2019新冠状病毒刺突蛋白S(RBD,FcTag)2019新冠状病毒刺突蛋白S(RBD,HisTag)2019新冠状病毒核蛋白NP重组人ACE-2蛋白(C-His)非典冠状病毒刺突蛋白S(S1)中东呼吸综合征冠状病毒刺突蛋白S(RBD)中东呼吸

快速眼动睡眠行为障碍（RBD）与抗抑郁药物治疗有关，但定量分析抗抑郁治疗与 RBD 患者快速眼动睡眠期肌肉迟缓障碍（RSWA）的研究相对较少。近期研究表明即使是无 RBD 的患者，抗抑郁治疗也与 RSWA 增加有关。这一结果显示抗抑郁药可能促进 RSWA 的发生。未来还需借助前瞻性研究来表明抗抑郁药物治疗与 RBD 之间的

系统，临床表现千差万别，主要包括：感觉障碍、精神障碍、自主神经功能障碍、睡眠障碍等，需给予积极治疗。注：RBD： 快速眼动期睡眠行为异常； RLS：不宁腿综合征

睡眠障碍是帕金森病（PD）最常见的非运动症状之一，其症状多样，包括日间嗜睡、入睡困难和快速眼动期睡眠行为障碍（RBD）等；而目前的药物治疗方法较少。既往研究显示可用的治疗药物包括褪黑激素、氯硝安定、雷沙吉兰等，但作用有限。光疗是睡眠医学中广泛应用的一种治疗方法，但目前尚无在 PD 患者中进行的系统性研究。为进一步明确

，临床表现千差万别，主要包括：感觉障碍、精神障碍、自主神经功能障碍、睡眠障碍等，需给予积极治疗。注：RBD： 快速眼动期睡眠行为异常； RLS：不宁腿综合征非

这一期《月度好文精选》来晚啦，因为药药忙着处理「专业版拼团」活动的用户反馈。虽然晚了一些，但我保证，这一期好文章绝对超值！8 月用药经验 TOP 5《临床医生...给药？》《五张表教你同类药物如何等效剂量换算》8 月用药问答 TOP 5《用药问答：输液时突然休克，谁是罪魁祸首？》《用药问答：急诊遇糖尿病急性并发症

2017 年 6 月 13 日，备受瞩目的 2016 SCI 期刊影响因子正式发布，儿科领域的各期刊的 IF 值有何变化？一起来看下吧。儿科领域 Top 10...。儿科领域Top 30至于第 19 名，儿科君搜了去年的前 50 也没找到，只能说是一匹黑马。。。具体查询方法进入网站：web of science

界面：依次选中 Data1：C：C，Reorder，Up 三个选项至 Data1：C：C 上升至第一列，再点击 OK（或者直接点击 Top，置于顶端也可以得到... 下移，Top 置于顶端，Bottom 置于底端，Reverse 反转数据列顺序（即顺序有 ABCDE 改变为 EDCBA）。此外，进入 Format Graph

推荐书」的 TOP.5 榜单吧！这是根据「医生阅读行为」调研活动中的 2102 份有效问卷得出的榜单，有很多医生推荐同行看这些书。看了医生推荐的 Top

、生物技术类药物、神经系统药物、抗感染药物和复方药物为排名居 TOP 5 的治疗领域。其中，癌症仍是药品研发的核心领域，抗癌/抗肿瘤药物数量呈现显著增长态势，数量...，与 2015 年数据进行对比，可反映不同治疗类别在研药物数量的变化情况。从治疗类别 TOP 25 排名中发现，一般抗癌药 (在研药物 2071 个)、免疫类

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

Payments by RMB (CNY)

• Payment by telegraphic transfer in CNY must be made to:
  A/C Name:
  A/C No.: 720-031103-001
  Beneficiary Bank:
  Bank Address: No. 1000 Lujiazui Rind Road,
  Pudong, Shanghai 200120, P.R. China
  Bank Swift Code: HSBCCNSH

CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.

本期「TOP list ·月度案例评选」是基于 6 月在丁香园医院汇平台上发布的文章，根据阅读量及点赞量呈现医疗行业「最受欢迎的品牌案例」TOP 10。医院汇努力为医疗行业从业者打造优秀品牌案例库，供行业宣传人士参考学习，也是众医院打造品牌曝光的重要营地。新闻资讯 TOP 10排名医院